Value-based, Personalized Care Models Increasingly Become Medtech’s Focus

by Ruth Seeley

As Asia-Pacific countries like Japan, China, Singapore, and India increasingly adopt emerging technologies, the region is poised to overtake Europe as the second largest medtech market by 2022, according to Frost & Sullivan’s “Global Medical Technologies Industry Predictions, 2019.”

“The medtech industry has been challenged by the lack of innovation in conventional segments, increasing focus on efficiencies, changing device ecosystem to digital enablers, and rising domestic competition in certain growth markets,” said Sowmya Rajagopalan, Advanced Medical Technologies Global Director. “This has resulted in a series of industry strategies broadly classified into increasing personalization, data and tech leverage, enhanced post-acute care coordination, and a focus on value-based care models.”

The Frost & Sullivan analysis looks at 20 such growth opportunities within this sub-sector, which has a combined incremental value of $64.10 billion over and above the $413.90 billion traditional market size. The estimates further peg the longer-term growth opportunity to be $173.06 billion by 2024, with a healthy CAGR of 22.0% compared to the traditional market, which is estimated to slow down from the current 5.8% to around 5.2% by 2024.

Medical Technology

“Patient centricity is a major theme for the medtech industry, with focus continuing to develop around key areas of patient safety, monitoring, engagement, and care coordination—but this time empowered with digital tools, and focusing on newer areas of growth,” said “Patient safety, for instance, which traditionally involves areas such as surgical site infections, is now expanding the scope to cover diagnostics safety, pressure ulcers and preventing unnecessary emergency department admissions. These newer focus areas are expected to grow at a 14.7% CAGR until 2024.”

Medtech strategies that tap growth opportunities

  • Companies are focusing on smartphone-based solutions, as they present a $2.11 billion opportunity by 2020. Technologies such as AI, machine learning, AR/VR, Internet of Things (IoT), and big data analytics, coupled with existing smartphone tools like cameras and external sensors, are transforming smartphones into powerful and cost-effective diagnostic tools.
  • Offer Software-as-a-Medical-Device (SaMD). These will become the building blocks of platforms of care aimed at holistic solutions for diagnosis, surgery, surgical navigation, treatment planning, and disease management.
  • Improve care-coordination and information exchange for patients to enhance their outcomes. Medtech companies are building risk-sharing contracts that are enabled only by data-sharing models, to understand the role of vendor solutions in care and outcomes management as a part of the overall strategy to become partners with hospitals.
  • Properly define the endpoints and measurement criteria to prevent disease adjacencies.
  • Foster partnerships with smart home ecosystem participants to aid early diagnosis and disease management and hence, ensure better outcomes.     

Source: Frost & Sullivan


Related Articles

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy